Pfizer Immunogenic Patent Targeted In New Petition For Inter Partes Review

(December 1, 2017, 8:28 AM EST) -- ALEXANDRIA, Va. — A patented immunogenic composition would have been obvious to a person of skill in the art, Sanofi Pasteur Inc. and SK Chemicals Co. Ltd. (Sanofi, collectively) assert in...
To view the full article, register now.